Predicted protein targets (top 12)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | SIRT2 | Q8IXJ6 | 6/20 | 0.46 |
| ▸ | KLK7 | P49862 | 2/20 | 0.44 |
| ▸ | KLK5 | Q9Y337 | 2/20 | 0.44 |
| ▸ | ITGB3 | P05106 | 1/20 | 0.41 |
| ▸ | ITGA2B | P08514 | 1/20 | 0.41 |
| ▸ | TPSAB1 | Q15661 | 2/20 | 0.41 |
| ▸ | HDAC1 | Q13547 | 1/20 | 0.41 |
| ▸ | HDAC2 | Q92769 | 1/20 | 0.41 |
| ▸ | TLR2 | O60603 | 1/20 | 0.41 |
| ▸ | TLR1 | Q15399 | 1/20 | 0.41 |
| ▸ | SIRT1 | Q96EB6 | 4/20 | 0.40 |
| ▸ | SIRT3 | Q9NTG7 | 3/20 | 0.40 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL31624506 | 0.94 | KLK7 (0.48) | SIRT2KLK7KLK5ITGB3ITGA2B | |
| SCHEMBL31624468 | 0.90 | TLR2 (0.40) | SIRT2KLK7KLK5ITGB3ITGA2B | |
| SCHEMBL31624488 | 0.90 | TLR2 (0.40) | SIRT2KLK7KLK5ITGB3ITGA2B | |
| SCHEMBL31624599 | 0.88 | SIRT2 (0.49) | SIRT2KLK7KLK5ITGB3ITGA2B | |
| SCHEMBL31624601 | 0.88 | SIRT2 (0.49) | SIRT2KLK7KLK5ITGB3ITGA2B | |
| SCHEMBL31624368 | 0.87 | HDAC1 (0.48) | SIRT2KLK7KLK5HDAC1HDAC2 | |
| SCHEMBL31624497 | 0.87 | HDAC1 (0.48) | SIRT2KLK7KLK5HDAC1HDAC2 | |
| SCHEMBL13049087 | 0.87 | TLR2 (0.47) | KLK7KLK5TLR2TLR1 | |
| SCHEMBL31631382 | 0.87 | SIRT2 (0.52) | SIRT2KLK7KLK5SIRT1SIRT3 | |
| SCHEMBL31631370 | 0.87 | SIRT2 (0.52) | SIRT2KLK7KLK5SIRT1SIRT3 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2025128626-A1 | HYBRID PEPTIDE COMPOUNDS HAVING A MODIFIED LYSINE RESIDUE | CARMOT THERAPEUTICS, INC. (US) | 2025-06-19 | — | — | WO | disclosed |
| WO-2025128624-A2 | HYBRID PEPTIDE COMPOUNDS HAVING A SUBSTITUTED TRYPTOPHAN RESIDUE OR A TERMINAL SUBSTITUENT | CARMOT THERAPEUTICS, INC. (US) | 2025-06-19 | — | — | WO | disclosed |